IL6 and type 2 diabetes mellitus: Indeed, biomarkers of inflammation such as leucocyte count, tumor necrosis factor α (TNFα), interleukin-6 (IL-6) and C-reactive protein are increased in obesity and predict the development of T2D [3], [4], [5], [6].